NP / PA
Aaa American Healthcare LLC
Aaa American Healthcare LLC was paid $1.43M by Medicaid between Jan 2018 and May 2022, across 23 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 41% of everything it billed.
33Billing provider infoAAA AMERICAN HEALTHCARE LLC
IDAHO FALLS, ID 83404
IDAHO FALLS, ID 83404
33aNPI1912378787assigned 10/19/2015
33bProvider typeNurse Practitioner
28Total paid$1.43M
24GClaims23,552
24DCodes billed23
24AFirst – last monthJan 2018 – May 2022
Compared with peers
Next to other Nurse Practitioner providers in Idaho
Rank by total paid#1 of 23
Median peer was paid$43K
This provider vs. median33×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,468 | $204K | |
| 2019 | 4,036 | $240K | |
| 2020 | 6,476 | $397K | |
| 2021 | 8,241 | $533K | |
| 2022 | 1,331 | $52K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 41% | 7,240 | 6,497 | $582K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29% | 7,335 | 6,575 | $417K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 9.4% | 861 | 103 | $134K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 5.4% | 569 | 516 | $77K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 4.1% | 1,091 | 1,019 | $58K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 2.8% | 146 | 123 | $40K |
| 95117 | 1.6% | 2,922 | 842 | $23K | |
| 80305 | 1.4% | 1,780 | 1,584 | $20K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 134 | 133 | $11K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 88 | 85 | $11K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 173 | 170 | $11K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 225 | 222 | $10K |
11 more codes
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | <1% | 225 | $8K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 281 | $5K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 89 | $4K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 88 | $4K |
| 99443 | <1% | 39 | $4K | |
| 99205 | Prolong outpt/office vis | <1% | 25 | $3K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 83 | $3K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 13 | $256.21 |
| 36415 | Collection of venous blood by venipuncture | <1% | 66 | $148.48 |
| 86769 | <1% | 53 | $3.38 | |
| 86328 | 0% | 26 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHATCH, ALBAN (MANAGER)